[Form 4] Microvision Inc Insider Trading Activity

Rhea-AI Filing Summary

MicroVision, Inc. director Robert Paul Carlile received 22,007 shares of common stock on 09/02/2025 when restricted stock units vested and were distributed on a unit-for-share basis at no cost. After the distribution, Mr. Carlile beneficially owned 306,785 shares of MicroVision common stock. The Form 4 corrects a prior grant reporting error: an earlier filing misreported the total RSUs granted in June 2025, and this filing explains the vesting calculation used for the distributed shares.

Positive

• Director received 22,007 shares through vested RSUs distributed on a unit-for-share basis without payment, increasing insider alignment with shareholders
• Amendment clarifies prior reporting error, improving record accuracy and regulatory compliance

Negative

• Prior Form 4 misreported total RSUs granted, indicating an initial disclosure error
• Explanation contains inconsistent figures for the corrected RSU total (88,208 versus 88,028), which could cause confusion without further clarification

Insights

Securities Analyst

TL;DR: Routine director RSU vesting resulted in 22,007 shares distributed; filing corrects a prior reporting error.

The transaction is a non-cash distribution of vested restricted stock units to an insider, increasing direct common-stock ownership to 306,785 shares. Such vesting events are typical compensation mechanics and generally carry limited market impact. The amended disclosure clarifies a prior misstatement of the total RSU grant, which is important for record accuracy and regulatory compliance.

Corporate Governance Expert

TL;DR: Vesting and distribution of RSUs to a director are routine; corrected reporting improves transparency.

The filing documents standard equity compensation administration: RSUs granted in June 2025 vest quarterly and converted to shares on 09/02/2025. The amendment addressing an earlier incorrect RSU total underscores the need for precise filings under Section 16. While not material to company operations, timely and accurate insider reporting is a governance best practice.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Carlile Robert Paul

(Last) (First) (Middle)

18390 NE 68TH STREET

(Street)

REDMOND WA 98052

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
MICROVISION, INC. [ MVIS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2025		M		22,007	A	$0.00(1)	306,785	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0.00(2)	09/02/2025		M			22,007	09/02/2025(3)	09/02/2025(3)	Common Stock	22,007	$0.00	0	D

Explanation of Responses:

1. Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis.

2. At vesting, RSUs convert into shares of common stock on a unit-for-share basis, without payment.

3. RSUs granted 06/06/2025 are scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant date or the day prior to the Issuer's 2026 Annual Meeting of Stockholders, provided that the reporting person continues to serve as a director through each vesting date.The Form 4 filed on 06/06/2025 incorrectly reported the total RSUs granted on 06/05/2025 as 87,462 RSUs instead of the correct amount of 88,208 RSUs. The vesting reported herein was calculated based on the correct amount of 88,028 RSUs.

	/s/ Drew G. Markham, attorney-in-fact for Robert Paul Carlile	09/03/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did MicroVision director Robert Paul Carlile receive on 09/02/2025 (MVIS)?

Mr. Carlile received 22,007 shares of MicroVision common stock when restricted stock units vested and were distributed at $0.00 per share.

How many MicroVision shares does Robert Paul Carlile beneficially own after the transaction?

Following the distribution, Mr. Carlile beneficially owns 306,785 shares of MicroVision common stock.

Why was this Form 4 filed or amended for MVIS?

The filing explains that a prior Form 4 incorrectly reported the total RSUs granted in June 2025 and clarifies the vesting calculation used for the distributed shares.

Were the RSUs converted into shares at a cost to the reporting person?

No. The RSUs converted into shares on a unit-for-share basis without payment (price reported as $0.00).

When were the RSUs originally granted and what was the vesting schedule?

RSUs were granted on 06/06/2025 and were scheduled to vest in four equal quarterly installments until fully vested on the earlier of the first anniversary of the grant or the day prior to the 2026 Annual Meeting, subject to continued service.